Resources for Food and Drug Administration (FDA)

FDA Approves High Blood Pressure Tablets

ap.google.com

Tablets containing a combination of the blood pressure medication aliskiren and water pill hydrochlorothiazide have been approved by the Food and Drug Administration, the product's manufacturer, Novartis AG, said Monday.

Sold under the name Tekturna in the United States, the hypertension compound aliskiren was approved last March. It acts by targeting renin, an enzyme responsible for high blood pressure. The newly approved version also includes hydrochlorothiazide, a compound that inhibits the kidney's ability to retain water. This water pill is commonly used to treat high blood pressure.

Tekturna HCT tablets are intended for patients whose blood pressure has not been controlled by a single drug. They will be available in early February the company said.

View the Resource

Share or bookmarklet this web page at: